Walking Assist Devices Market - Global Growth, Trends, and Forecast | MarketsandMarkets™

According to the new market research report “Walking Assist Devices Market by Product Type (Gait Belts & Lift Vests, Canes, Crutches, Walker, Wheelchairs, Power Scooters), and Region (North America, Europe, Asia-Pacific and ROW) - Global Forecast to 2020",published by MarketsandMarkets™. The global walking assist devices market is expected to reach USD 6.57 Billion by 2020, at a CAGR of 3.9% from 2015 to 2020.

Don’t miss out on business opportunities in Walking Assist Devices Market.

The global market is expected to witness growth in the coming years, owing to factors such as the increase in the number of initiatives undertaken by governments of various countries to ensure availability of walking assist devices to a huge consumer base, rise in aging population, and increasing incidences of Debilitating Neurological Diseases & Injuries. Moreover, the trends in patient community and growing technological advancements & product leasing are also expected to drive the growth of the market. However, cost of purchase of walking assist devices is high.

Global market is broadly classified on the basis of product and geography. Based on product, the market is broadly segmented into gaits belts and lift vests, canes, crutches, walkers, wheelchairs, and power scooters. The wheelchairs segment contributed the largest share of the market in 2014. The geography covered in this report are North America, Europe, Asia-Pacific and Rest of the World (RoW). The market in North America accounted for the largest share of the global market in 2014.

Browse and in-depth TOC on "Walking Assist Devices Market"

108  - Tables

112  - Figures

Get Free 10% customization: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=24035174

Market Segmentation, by Product:

o   Gaits Belts & Lift Vests,

o   Canes

o   Crutches

o   Walkers

o   Wheelchairs

o   Power scooters

Customization Options

Along with market data, customize the MNM assessments to meet your company’s specific needs. Customize to get a comprehensive summary of the industry standards and a detailed analysis of the following parameters:

1.      Product Analysis

o   Usage pattern (in-depth trend analysis) of products (segment-wise)

o   Product matrix, which gives a detailed comparison of product portfolio of each company, mapped at country and subsegment level

o   End user adoption rate analysis of the products (segment-wise and country-wise)

o   Comprehensive coverage of product approvals, volume data, pipeline products, and product recalls

2.      Brand/Product Perception Matrix

o   Comprehensive study of customers perception and behavior through our inbuilt social connect tool checking virality and tonality of blogs

o   Analysis of overall brand usage and familiarity, and brand advocacy distribution (detractor/neutral/familiar)

3.      1.1.3 PO RT E R ’S FI V E FO RC E S Analysis

o   Detailed account of the nature of bargaining power of the suppliers and the buyers

o   Degree and intensity of rivalry of the peer players and threat from the new entrants

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Cell Therapy Technologies Market by Product, Cell Type & End User| MarketsandMarkets™

According to the new market research report "Cell Therapy Technologies Market by Product (Consumables, Equipment, Software), Cell Type (Human Stem & Differentiated, Animal), Process Stages (Cell Processing, Distribution, Handling, QC), End User, and Region - Global Forecast to 2023",            published by MarketsandMarkets™, The global cell therapy technologies market is projected to reach USD 19.9 billion by 2023 from USD 10.2 billion in 2018, at a CAGR of 14.4% during the forecast period.

Don’t miss out on business opportunities in Cell Therapy Technologies Market.

Rising government investments for cell-based research, the increasing number of GMP-certified production facilities, and the large number of oncology-oriented cell-based therapy clinical trials are the key factors driving the growth of this cell therapy technologies market.

Consumables are expected to account for the largest cell therapy technologies market share in 2018

By product, the cell therapy technologies market is segmented into consumables, equipment, and systems & software. The consumables segment is expected to account for the largest share of the market in 2018. Factors such as increasing investments by companies to develop advanced products as well as government initiatives for enhancing cell-based research are contributing to the growth of the cell therapy consumables market.

To know about the assumptions considered for the study, download the pdf brochure

Browse and in-depth TOC on " Cell Therapy Technologies Market "

75  - Tables

30 - Figures

116  - Pages

Get Free 10% customization: 

https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=213334978

Cell processing segment to witness the highest growth during the forecast period

Based on process, the cell therapy technologies market is segmented into cell processing; cell preservation, distribution, and handling; and process monitoring and quality control. The cell processing segment is expected to account for the largest market share in 2018 and is projected to witness the highest CAGR during the forecasted period. The cell processing stage makes the highest use of cell therapy instruments and media, especially during culture media processing. This is the major factor responsible for the large share and high growth of this segment.

Key Market Players

Key players in this cell therapy technologies market include Beckman Coulter (US), Becton, Dickinson and Company (US), GE Healthcare (US), Lonza (Switzerland), Merck KGaA (Germany), Miltenyi Biotec (Germany), STEMCELL Technologies, Inc. (Canada), Terumo BCT (US), and Thermo Fisher Scientific (US).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Immunotherapy Drugs Market by Type of Drug, Size, Share| MarketsandMarkets™

According to the new market research report "Immunotherapy Drugs Market by Type of Drugs (Adult Vaccines, Checkpoint Inhibitors, Interferons Alpha), Therapy Area (Cancer, Autoimmune Diseases, Infectious Diseases), End-User (Hospitals), Region (North America, Asia-Pacific) - Global Forecast to 2021", published by MarketsandMarkets™,The global immunotherapy drugs market is projected to reach USD 201.52 Billion by 2021 from USD 108.41 Billion in 2016, growing at a CAGR of 13.5% during the forecast period of 2016 to 2021.

Don’t miss out on business opportunities in Immunotherapy Drugs Market

Increasing adoption of targeted therapies with fewer side effects, quicker drug approval processes, and high prevalence rate of lifestyle diseases are major growth drivers of this market. On the other hand, the high cost of immunotherapy treatment, and high attrition rate in the product development cycle are the major factors hindering the growth of the market.  However, rising opportunities in the emerging markets, and immunotherapy as an alternative to chemotherapy for first line treatment are the factors supporting the growth of the market.

Target Audience

Pharmaceuticals Manufacturers

Research & Academic Institutions

Hospitals and clinics

Contract Manufacturers

Contract Research Organizations

To know about the assumptions considered for the study, download the pdf brochure

Browse and in-depth TOC on "Immunotherapy drugs Market"

79  - Tables

44  - Figures

174  - Pages

Immunotherapy drugs Market, by Therapy Area

·         Cancer

·         Solid Tumor

·         Malignant

·         Autoimmune & Inflammatory Diseases

·         Infectious Diseases

·         Others

Get Free 10% customization: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=137717755

Company Information

Detailed analysis and profiling of additional market players

The global immunotherapy drugs market is projected to reach USD 201.52 Billion by 2021 from USD 108.41 Billion in 2016, growing at a CAGR of 13.5% during the forecast period of 2016 to 2021.

Increasing adoption of targeted therapies with fewer side effects, quicker drug approval processes, and high prevalence rate of lifestyle diseases are major growth drivers of this market. On the other hand, the high cost of immunotherapy treatment, and high attrition rate in the product development cycle are the major factors hindering the growth of the market.  However, rising opportunities in the emerging markets, and immunotherapy as an alternative to chemotherapy for first line treatment are the factors supporting the growth of the market.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Synthetic Biology Market Size, Share Growth,Trends and Forecast| MarketsandMarkets™

According to the new market research report "Synthetic Biology Market by Tool (Oligonucleotides, Chassis Organisms, Enzymes), Technology (Genome Engineering, NGS, Cloning and Sequencing), Application (Medical (Pharmaceutical, Drug Discovery), Industrial (Renewable Energy)) - Global Forecast to 2022", published by MarketsandMarkets™, The global synthetic biology market is expected to grow from USD 3.57 billion in 2017 to USD 8.84 billion by 2022, at a CAGR of 19.9% from 2017 to 2022.

Don’t miss out on business opportunities in Synthetic Biology Market  

Synthetic biology has an array of applications in the fields of medicine, agriculture, nanotechnology, and industrial biotechnology. This has attracted interests of researchers from across the globe and has led to a rise in funding from public and private organizations, which, in turn, help in the growth of the market. Additionally, the reduction in costs per raw megabase of DNA sequencing and a drastic reduction in the cost of synthetic genes is expected to propel the market growth of synthetic biology. The base year considered for the study is 2016, and the forecast has been provided for the period between 2017 and 2022.

Wide range of applications of synthetic biology drives the global synthetic biology market

The field of medicine has been in the forefront in terms of developing and applying synthetic biology techniques for various applications. Advancements in DNA sequencing and synthesizing technologies have resulted in the better understanding of diseases, aiding the research and discovery of biopharmaceuticals, small molecules, regenerative medicine, and antibody research.

Browse and in-depth TOC on "Synthetic Biology Market"

121 - Tables

32 - Figures

214 - Pages

Get Free 10% customization:

https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=889

The synthetic biology market comprises a network of players involved in the research and product development; raw material supply; component manufacturing; distribution and sale; and post-sales services. Key players considered in the analysis of the global market are Thermo Fisher (US), Novozymes (Denmark), Merck KGaA (Germany), Intrexon (US), and Agilent Technologies (US), Amyris (US), GenScript (US), Ginkgo Bioworks (US), Integrated DNA Technologies (US), New England Biolabs (US), Synthetic Genomics (US), and Twist Bioscience (US).

To know about the assumptions considered for the study, download the pdf brochure

Major Market Developments:

In 2017, Thermo Fisher (US) collaborated with AstraZeneca (US) and offered its CRISPR technology to AstraZeneca’s entire drug discovery platform.  In 2017, Ginkgo Bioworks (US) acquired Gen9 (US), a Cambridge based gene synthesis company.  In 2017, Intrexon (US) collaborated with Johnson Matthey (UK) to develop microbial strains for fermentative production of peptide-based active pharmaceutical ingredients (APIs)

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Orthobiologics Market Prospective Growth, Opportunities | MarketsandMarkets™

According to the new market research report " Orthobiologics Market by Product (Viscosupplementation, Synthetic Orthobiologics, DBM, BMP, PRP, BMAC, Allograft), Application (Fracture Recovery, Osteoarthritis, Spinal Fusion, Soft Tissue), End User (Hospitals, ASCs, Academia) - Global Forecast to 2022", published by MarketsandMarkets™, The global orthobiologics market is expected to reach USD 6.06 Billion by 2022 from USD 4.44 Billion in 2016 at a CAGR of 5.4% during the forecast period.

Don’t miss out on business opportunities in Orthobiologics Market

Orthobiologics Market : Years considered for the study are as follows

·         Base Year: 2016

·         Forecast Period: 2017–2022

Orthobiologics Market : Objectives of the study are

·         To define, describe, and forecast the orthobiologics market on the basis of product, application, end user, and region

·         To provide detailed information regarding the major factors influencing growth of the market (drivers, restraints, opportunities, and challenges)

·         To strategically analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the market

·         To analyze the opportunities in the market for key stakeholders and provide details of the competitive landscape for major market leaders

To know about the assumptions considered for the study, download the pdf brochure

Browse and in-depth TOC on "Orthobiologics Market"

60  - Tables

38  - Figures

159  - Pages

Get Free 10% customization:

https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=162747970

This research study involves the extensive usage of secondary sources, directories, and databases (such as Hoover’s, Bloomberg Business, Factiva, and Avention), in order to identify and collect information useful for this technical, market-oriented, and financial study of the market. In-depth interviews were conducted with various primary respondents, including subject-matter experts (SMEs), C-level executives of key market players, and industry consultants to obtain and verify qualitative and quantitative information and to assess market prospects.

As of 2016, Medtronic, DePuy Synthes, and Zimmer Biomet held the leading position in the market. These companies adopted product launches, agreements, and partnerships as their business strategies in past three years to ensure market dominance. Stryker, Bioventus, Harvest Technologies, Globus, Orthofix International, RTI Surgical, K2M Group, Kuros Biosciences, NuVasive, SeaSpine, and Xtant Medical are some of the other major players in this market.

Company Information

Detailed analysis and profiling of additional orthobiologics market players (up to 15)

The global orthobiologics market is projected to reach USD 6.06 Billion by 2022 from USD 4.66 Billion in 2017, at a CAGR of 5.4% during the forecast period. Factors such as rising burden of orthopedic injuries; increasing incidence of sports injuries and road accidents; increasing incidence of spinal fusion surgeries; risk factors associated with increasing aging population, obesity rate, & high incidence of musculoskeletal disorders; and growing patient preference for minimally invasive procedures are driving the market.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Overactive Bladder Treatment Market| Biopharma | Research & reports | DRG | MarketsandMarkets™

The overactive bladder treatment market includes various therapies, namely, anticholinergics, mirabegron, BOTOX, and neurostimulation used to treat the sudden, involuntary contraction of the muscle in the urinary bladder wall leading to urinary urgency, frequency, nocturia, and urge-incontinence. The global market is projected to be valued at USD 3.63 Billion in 2017 and is expected to grow at a CAGR of 2.9% during the forecast period to reach to USD 4.19 Billion by 2022. Base year considered for the report is 2016. The development of innovative intravesical therapies, aggressive marketing by pharma companies, and favorable demographics are the key factors driving the growth of the market.

To know about the assumptions considered for the study, download the pdf brochure

Objectives of the Study

• ·         To define, describe, and forecast the global Overactive Bladder Treatment market on the basis of pharmacotherapy, disease type, and region
• ·         To provide detailed information regarding the major factors influencing growth of the market (drivers, restraints, trends, opportunities, and challenges)
• ·         To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the global market
• ·         To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders

Browse and in-depth TOC on "Overactive Bladder Treatment Market"

53 - Tables

39 - Figures

236 - Pages

Get Free 10% customization:

https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=219938791

Research Methodology

Top-down and bottom-up approaches were used to validate the size of the global Overactive Bladder Treatment market and estimate the size of other dependent submarkets. Various secondary sources such as associations, including American Urology Association, National Center for Biotechnology Information, U.S. National Library of Medicine, European Association of Urology, Urology Care Foundation, National Association For Continence, National Institutes of Health (NIH), Pharmaceutical Research and Manufacturers of America, Centers for Disease Control and Prevention (CDC), U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), directories, industry journals, databases, and annual reports of the companies have been used to identify and collect information useful for the study of market.  

Target Audience:

• ·         Drug manufacturers, vendors, and distributors
• ·         Academic and government research institutes
• ·         Contract manufacturing organizations (CMOs) and contract research organizations (CROs)
• ·         Venture capitalists and investors

Overactive Bladder Treatment Market, by Disease Type

·         Idiopathic Bladder Overactivity

·         Neurogenic Bladder Overactivity

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Trauma Products Market Size, Share, Forecast | MarketsandMarkets™

According to the new market research report "Trauma Products Market by Type (Internal (Screw, Nails, Staples), External Fixator (Circular, Unilateral, Hybrid)), Surgical Site (Hand, Shoulder, Arm, Elbow, Hip, Pelvis, Knee, Leg, Thigh, Feet, Ankle), End User (Hospital, ASC) - Global Forecast to 2022", published by MarketsandMarkets™, the trauma products market is expected to reach USD 8.43 Billion by 2022 from USD 5.98 Billion in 2017, at a CAGR of 7.1% during the forecast period.

Don’t miss out on business opportunities in Trauma Products Market

The objectives of this study are as follows:

·         To define, describe, and forecast the market by type, surgical site, end user, and region

·         To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, and industry-specific challenges)

·         To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the market

·         To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders

·         To forecast the size of the market segments with respect to four main regions, namely, North America, Europe, Asia, and the Rest of the World (RoW)

Browse and in-depth TOC on " Trauma Products Market "

105 - Tables

43 - Figures

187 - Pages

Get Free 10% customization:

https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=213911560

Research Methodology

The study estimates the trauma products market size for 2017 and projects its demand till 2022. In the primary research process, various sources from both demand side and supply side were interviewed to obtain qualitative and quantitative information of the report. Primary sources from the demand side include various industry CEOs, vice presidents, marketing directors, technology and innovation directors, and related key executives from the various players in the market. Primary sources from the demand include hospitals, clinics, and ambulatory surgical centers.

To know about the assumptions considered for the study, download the pdf brochure

Target Audience for this Report:

·         Trauma product manufacturers

·         Healthcare institutions (hospitals and trauma centers)

·         Trauma product distributors and suppliers

·         Contract manufacturing organizations (CMOs)

·         Teaching hospitals and academic medical centers (AMCs)

·         Research and consulting firms

·         Academic centers

Company Information

The trauma products market is expected to reach USD 8.43 Billion by 2022 from USD 5.98 Billion in 2017, at a CAGR of 7.1% during the forecast period. A number of factors such as growth in geriatric population, the high prevalence of bone degenerative diseases, and increasing incidence of road accidents are driving the demand for trauma products. On the other hand, the possibility of allergies associated with the implantation of trauma products and a lack of trained professionals are some of the factors that may hinder the overall growth of this market.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Cannabis Testing Market | Growth, Trends, and Forecast| MarketsandMarkets™

According to the new market research report "Cannabis Testing Market by Product & Software (LC, GC, Spectroscopy (MS, Atomic), Column, Standards, Accessories, LIMS), Service (Potency, Pesticides, Heavy Metal, Genetic Testing), End User (Lab, Pharmaceutical, Research) - Global Forecast to 2021", published by MarketsandMarkets™, the overall cannabis testing market expected to reach USD 1,416.3 million by 2021 from USD 822.0 million in 2016, at a CAGR of 11.5% of during the forecast period (2016-2021)

Don’t miss out on business opportunities in Cannabis Testing Market Size

Owing to various social and political factors, cannabis has been banned in most countries since the early 1900s. At present, many countries are increasingly recognizing the benefits of cannabis for medicinal purposes and are hence approving its use.

Legalization fo medical cannabis coupled with the growing number of cannabis testing laboratories

Medical cannabis is proven to be effective in various medical applications, such as reducing nausea caused due to chemotherapy, stimulating appetite in AIDS patients, controlling muscular spasms in multiple sclerosis patients, and reducing intraocular pressure in patients with glaucoma. Owing to these potential health benefits, governments in various countries are legalizing the use of medical cannabis. Countries including Australia (2016), Canada (2015), North Korea, Spain, Portugal (2001), the U.K. (2006), Germany (awaiting approval by the end of 2017), Italy, the Netherlands, Israel, and Brazil have legalized the use of medical cannabis in recent years. Moreover, in the U.S., 25 states have legalized medical cannabis; four states Colorado, Washington, Oregon, and Alaska—have legalized cannabis for both medical and recreational use.

Browse and in-depth TOC on " Cannabis Testing Market "

160  - Tables

49  - Figures

203 - Pages

Legalization fo medical cannabis coupled with the growing number of cannabis testing laboratories

Medical cannabis is proven to be effective in various medical applications, such as reducing nausea caused due to chemotherapy, stimulating appetite in AIDS patients, controlling muscular spasms in multiple sclerosis patients, and reducing intraocular pressure in patients with glaucoma. Owing to these potential health benefits, governments in various countries are legalizing the use of medical cannabis. Countries including Australia (2016), Canada (2015), North Korea, Spain, Portugal (2001), the U.K. (2006), Germany (awaiting approval by the end of 2017), Italy, the Netherlands, Israel, and Brazil have legalized the use of medical cannabis in recent years. Moreover, in the U.S., 25 states have legalized medical cannabis; four states Colorado, Washington, Oregon, and Alaska—have legalized cannabis for both medical and recreational use.

To know about the assumptions considered for the study, download the pdf brochure

The following are the major objectives of the study : Cannabis Testing Market

To define, describe, and forecast the global cannabis testing market on the basis of product and software, service, end user, and region

To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and industry-specific challenges)

To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the overall market

To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders

To forecast the market size of market segments with respect to four main regions (along with the countries), namely, North America, Europe, Asia-Pacific, and LATAM & MEA

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

3D Bioprinting Market | Growth, Trends and Forecasts‎ | MarketsandMarkets™

According to the new market research report "3D Bioprinting Market by Technology (Microextrusion, Inkjet, Laser, Magnetic), Material (Cells, Hydrogels, Extracellular Matrices, Biomaterials), Application (Clinical (Bone, Cartilage, Skin) & Research (Regenerative Medicine)) - Global Forecasts to 2021", published by MarketsandMarkets™,the global market is projected to reach USD 1.33 billion by 2021 at a CAGR of 26.5% during forecast period. 

Don’t miss out on business opportunities in 3D Bioprinting Market

The key factor driving the growth of the market is the rising demand for organ transplantation across the globe. In addition, growing R&D in the field of 3D bioprinting, increasing public and private investments to support 3D bioprinting research, and rising use of 3D bioprinting in drug discovery are supporting the growth of this market. On the other hand, limitations of biomaterial-based products and socio-ethical concerns are the major challenges in this market.

3D Bioprinting Market : Target Audience

·         3D Bioprinter manufacturers, suppliers, and distributors

·         Pharmaceutical & biotechnology companies

·         Cosmetic product manufacturers, suppliers, and distributors

·         Healthcare institutions

·         Clinical diagnostic centers

·         Medical research laboratories

·         Academic medical centers and universities

·         Business research and consulting firms

To know about the assumptions considered for the study, download the pdf brochure

Browse and in-depth TOC on "3D Bioprinting Market"

74   - Tables

39   - Figures

143  - Pages

Get Free 10% customization: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=170201787

Global 3D Bioprinting Market, by Region

·         North America

·         Europe

·         Asia-Pacific

·         Rest of the World

3D Bioprinting Market : Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Product Analysis

Product matrix, which gives a detailed comparison of the product portfolios of the top five companies in the market

Company Information

Detailed analysis and profiling of additional market players (up to 5)

To speak to our analyst for a discussion on the above findings, click Speak to Analyst